Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers

Circulation

Volumn 108, Issue 1, 2003, Pages 24-31

  Carroll, Mary F ^a   Schade, David S ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Antioxidants; Plasminogen activator inhibitor; Protein, C reactive

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 6; MALONALDEHYDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VITAMIN;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DISEASE MARKER; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MEAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE;

ADMINISTRATION, ORAL; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREE RADICAL SCAVENGERS; GLUCOSE CLAMP TECHNIQUE; HUMANS; INTERLEUKIN-6; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTPRANDIAL PERIOD; TIME FACTORS; TRIGLYCERIDES; VITAMIN E; VITAMINS;

EID: 0038164595     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000074221.68903.77     Document Type: Article

References (35)

1. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 1979;278:737-738.
2. Devaraj S, Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of α-tocopherol supplementation. Circulation. 2000;102:191-196.
3. Devaraj S, Cabo Chan AV, Jialal I. α-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetes patients. Diabetes Care. 2002;25:524-529.
4. Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med. 2000;29:790-792.
5. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA. 1997;278:1682-1686.
6. Kaufmann PA, Gnecchi-Ruscone T, Di Terlizzi M, et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation. 2000;102:1233-1238.
7. Salonen JT, Nyyssonen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention Study (ASAP): a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med. 2000;248:377-386.
8. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
9. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356:1213-1218.
10. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
11. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
12. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet. 2001;357:89-95.
13. Ahmed M, Gannon MC, Nuttall FQ. Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects. Diabetologia. 1976;12:61-67.
14. Sharrett AR, Chambless LE, Heiss G, et al. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 1995;15:2122-2129.
15. Nappo F, Esposito K, Cioffi M, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39:1145-1150.
16. Williams MJ, Sutherland WH, McCormick MP, et al. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol. 1999;33:1050-1055.
17. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care. 1998;21:1529-1533.
18. Nielson SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA. 2003;289:450-453.
19. Ghiselli A, Serfafini M, Maiani G, et al. A fluorescence-based method for measuring total plasma antioxidant capacity. Free Radic Biol Med. 1995;18:29-36.
20. Balkau B, Shipley M, Jarret RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study and the Helsinki Policeman Study. Diabetes Care. 1998;21:360-367.
21. Lewis GF, O'Meara NM, Soltys PA, et al. Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab. 1991;72:934-944.
22. Brigelius-Flohe R, Traber M. Vitamin E: function and metabolism. FASEB J. 1999;13:1145-1155.
23. Sharma A, Kharb S, Chugh SN, et al. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism. 2000;49:160-162.
24. Luliano L, Micheletta F, Maranghi M, et al. Bioavailability of vitamin E as function of food intake in healthy subjects. Arterioscler Thromb Vasc Biol. 2001;21:e34-e37.
25. Sothern RB, Roitmen-Johnson B, Kanabrocki EL, et al. Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol. 1995;95:1029-1035.
26. Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 2001;47:426-430.
27. Ockene IS, Matthews CE, Rifai N, et al. Variability and classification accuracy of serial high sensitivity C-reactive protein measurements in healthy adults. Clin Chem. 2001;47:444-450.
28. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481-2485.
29. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993;91:1351-1357.
30. Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyperglycemia and impaired hemostasis: the Framingham offspring study. JAMA. 2000;283:221-228.
31. Juhan-Vague I, Pyke SD, Alessi MC, et al. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group European Concerted Action on Thrombosis and Disabilities. Circulation. 1996;94:2057-2063.
32. Sobel BE, Woodcock-Mitchell J, Scneider DJ, et al. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with non-diabetic patients. Circulation. 1998;97:2213-2221.
33. Juhan-Vague I, Alessi MC, Raccah D, et al. Daytime fluctuations of plasminogen activator inhibitor-1 (PAI-1) in populations with high PAI-1 levels. Thromb Haemost. 1992;67:76-82.
34. Calles-Escandon J, Mirza SA, Sobel B, et al. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor-1 in blood in normal human subjects. Diabetes. 1998;47:290-293.
35. Ren S, Shen GX. Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cell. Arterioscler Thromb Vasc Biol. 2000;20:1688-1693.